185 related articles for article (PubMed ID: 15504874)
1. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
Credito KL; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT; Bryskier A
Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322
[TBL] [Abstract][Full Text] [Related]
3. Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin.
Ednie L; Shapiro S; Appelbaum PC
Diagn Microbiol Infect Dis; 2007 May; 58(1):133-6. PubMed ID: 17240107
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214
[TBL] [Abstract][Full Text] [Related]
5. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
Behra-Miellet J; Dubreuil L; Calvet L
Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
[TBL] [Abstract][Full Text] [Related]
7. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Ednie LM; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
[TBL] [Abstract][Full Text] [Related]
8. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of imipenem against gram-positive anaerobic bacteria.
Dubreuil L; Devos J; Romond C
Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
[TBL] [Abstract][Full Text] [Related]
10. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of OPT-80 against Clostridium difficile.
Ackermann G; Löffler B; Adler D; Rodloff AC
Antimicrob Agents Chemother; 2004 Jun; 48(6):2280-2. PubMed ID: 15155234
[TBL] [Abstract][Full Text] [Related]
17. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study].
Grollier G; Mory F; Quentin C; Girard-Pipau F; Tigaud S; Sedallian A; Dubreuil L
Pathol Biol (Paris); 1994 May; 42(5):498-504. PubMed ID: 7824321
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.
Citron DM; Warren YA; Tyrrell KL; Merriam V; Goldstein EJ
J Antimicrob Chemother; 2009 May; 63(5):972-6. PubMed ID: 19240076
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Nani E; Amato G; Anzivino D; Covelli B; Lembo M
Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
